A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

There's a fine line when it comes to using ketamine -- and from Chrissy Teigen to Matthew Perry, these stars have explored it ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...

Depression is a pervasive mental health condition affecting millions of people worldwide. It can manifest in various ways, from persistent sadness to a lack of energy or interest in daily activities.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The symptoms of mental health disorders and chronic pain affect every facet of life, especially during the dark, cold days of ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...